Genetic factors in hypertension. Angiotensin-converting enzyme polymorphism;Uwarunkowania genetyczne nadciśnienia tȩtniczego: Polimorfizm genu enzymu konwertuja̧cego angiotensynȩ

Kardiologia Polska

Volumn 61, Issue 7, 2004, Pages 1-11

  Czarnecka, Danuta ^a,b   Kawecka Jaszcz, Kalina ^a,b   Stolarz, Katarzyna ^a,b   Olszanecka, Agnieszka ^a,b   Kieć Wilk, Beata ^a,b   Dembińska Kieć, Aldona ^a,b   Narkiewicz, Krzysztof ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

24 hour ambulatory blood pressure monitoring; Angiotensin converting enzyme polymorphism; Blood pressure; Carotid intima media thickness

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE MASS; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PARENT; POLYMERASE CHAIN REACTION; PROGENY; QUANTITATIVE TRAIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 3342990118     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hall J.H., Mizelle H.L., Woods L.L.: The renin-angiotensin system and long-term regulation of blood pressure. J. Hypertens. 1986, 4, 387-397.
2. Dzau V.J.: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch. Intern. Med. 1993, 153, 937-942.
3. Gaciong Z., Religa P., Placha G.: Polimorfizm genetyczny w obrȩbie układu renina-angiotensyna. Znaczenie dla rozwoju chorób układu kra̧żenia. Kardiol. Pol. 1998, 48, II-39 - II-43.
4. Danser A.H.J., Schalekamp M.A.D.H., Bax W.A. et al.: Angiotensin- converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92, 1387-1388.
5. Kuznetsova T., Staessen J.A., Kawecka-Jaszcz K. et al.: Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit. 2002, 7, 215-224.
6. Schiller N.B., Shah P.M., Crawford M. et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J. Am. Soc. Echocardiogr. 1989, 2, 358-367.
7. Rigat B., Hubert C., Corvol P., Soubrier F.: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic. Acids Res. 1992, 20, 1433.
8. Abecasis G.R., Cardon L.R., Cookson W.O.C.: A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 2000, 66, 279-292.
9. Allison D.B.: Transmission-disequilibrium test for quantitative traits. Am. J. Hum. Genet. 1997, 60, 676-690.
10. Staessen J.A., Wang J.G., Ginocchio G. et al.: The deletion/insertion polymorphism of the converting-enzyme and cardiovascular-renal risk. J. Hypertens. 1997, 15, 1579-1592.
11. Bellwon J., Gruchata M., Siebert J. et al.: Współ wystȩpowanie wariantów polimorficznych 1/D genu ACE i A1166C receptora AT1 angiotensyny II a ciśnienie tȩtnicze u mȩżczyzn bez jawnych klinicznie schorzeń miażdż ycopochodnych. Nadciśnienie Tȩtnicze 2000, 4, 261-268.
12. Dzida G., Sobstyl J., Pużniak A et al.: Polymorphism of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in Polish population. Med. Sci. Monit. 2001, 7, 1236-1241.
13. Buraczyńska M., Pijanowski Z., Spasiewicz D. et al.: Polimorfizm genów układu renina-angiotenysna a ryzyko choroby wieńcowej serca. Kardiol. Pol. 2003, 58, 1-4.
14. O'Donnell C.J., Lindpaintner K., Larson M.G. et al.: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998, 97, 1766-1772.
15. Staessen J.A., Wang J.G., Brand E. at al.: Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J. Hypertens. 2001, 19, 1349-1358.
16. Vakili B.A., Okin P.M., Devereux R.B.: Prognostic implications of left ventricular hypertrophy. Am. Heart J. 2001, 141, 334-341.
17. Levy D., Anderson K.M., Savage D.D. et al.: Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann. Intern. Med. 1988, 108, 7-13.
18. Narkiewicz K., Dudziak M., Kubasik A. et al.: Wpływ czynników genetycznych na morfologiȩ i funkcjȩ lewej komory serca w grupie młodych zdrowych bliźnia̧t. Kardiol. Pol. 1998, 48, 221.
19. Narkiewicz K., Jagoda J., Chrostowska M. et al.: Gen konwertazy angiotensyny I a morfologia i funkcja lewej komory u młodych zdrowych mȩżczyzn. Kardiol. Pol. 1997, 46, 304-309.
20. Kuznetsova T., Staessen J.A., Wang J.G. et al.: Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J. Hum. Hypertens. 2000, 14, 447-454.
21. Girerd X., Hanon O., Mourad J.J. et al.: Lack of association between renin-angiotensin system, gene polymorphisms, and wall thickness of the radial and carotid arteries. Hypertension 1998, 32, 579-583.
22. Markus H.S., Barley J., Lunt R. et al.: Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995, 26, 1329-1333.